García Montoya, Encarna
Encarna Garcia_Montoya researcher
VIAF ID: 305875365 ( Personal )
Permalink: http://viaf.org/viaf/305875365
Preferred Forms
4xx's: Alternate Name Forms (4)
Works
| Title | Sources |
|---|---|
| Aportación al estudio tecnológico de comprimidos bucodiSpersables por compresión directa |
|
| Approach to design space from retrospective quality data. |
|
| Characterization of alginate beads loaded with ibuprofen lysine salt and optimization of the preparation method. |
|
| Chitosan nanoparticles as non-viral gene delivery systems: determination of loading efficiency. |
|
| Cholesteryl oleate-loaded cationic solid lipid nanoparticles as carriers for efficient gene-silencing therapy. |
|
| Coenzyme Q10 supplementation: Efficacy, safety, and formulation challenges |
|
| Desenvolupament, caracterització i avaluació d’una nova forma farmacèutica basada en micro-comprimits d’alliberació modificada |
|
| Development and Validation of a Stability Indicating RP-HPLC Method for Hydrocortisone Acetate Active Ingredient, Propyl Parahydroxybenzoate and Methyl Parahydroxybenzoate Preservatives, Butylhydroxyanisole Antioxidant, and Their Degradation Product |
|
| Estudio galénico comparativo de comprimidos de ibuprofeno |
|
| Formación práctica en tecnología farmacéutica N.C.F. en la fabricación de emulsiones |
|
| Formulation of Sustained Release Hydrophilic Matrix Tablets of Tolcapone with the Application of Sedem Diagram: Influence of Tolcapone's Particle Size on Sustained Release |
|
| New classification of directly compressible |
|
| A new expert systems (SeDeM diagram) for control batch powder formulation and preformulation drug products. |
|
| Optimización en la fabricación de medicamentos según ICH Q8, Q9 y Q10 aplicación a comprimidos recubiertos mediante diseño experimental de datos retrospectivos |
|
| Optimización, validación y modelización de un proceso de fabricación de comprimidos desarrollo de una aplicación interactiva multimedia |
|
| Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system. |
|
| Preformulation and characterization of a lidocaine hydrochloride and dexamethasone sodium phosphate thermo-reversible and bioadhesive long-acting gel for intraperitoneal administration. |
|
| Quality and integrity of data in research, development, and innovation: a risk analysis method applied to laboratory notebooks in a university pilot plant. |
|
| Quality by Design approach to understand the physicochemical phenomena involved in controlled release of captopril SR matrix tablets. |
|
| Relationships between surface free energy, surface texture parameters and controlled drug release in hydrophilic matrices |
|
| Robustness Optimization of an Existing Tablet Coating Process Applying Retrospective Knowledge (rQbD) and Validation |
|
| SeDeM expert system a new innovator tool to develop pharmaceutical forms. |
|
| Trends in the food and sports nutrition industry: A review |
|
| The use of the SeDeM diagram expert system for the formulation of Captopril SR matrix tablets by direct compression. |
|
| Validació de radiofàrmacs PET per al seu ús en humans |
|
| Validación de los procesos de limpieza en la industria farmacéutica, mediante la aplicación del análisis de riesgo, seguridad toxicológica y UPLC |
|
